Results 1 to 10 of about 11,363 (186)
Elevated Serum CTACK/CCL27 Levels in CTCL [PDF]
Journal of Investigative Dermatology, 2006 Bulk ionic composition of the aerosol at Kohnen in January ...
Kagami, Shinji +6 more
core +4 more sources
Estrogen receptor β stimulation as a possible novel therapeutic target for cutaneous T-cell lymphoma [PDF]
Blood Advances: Cutaneous T-cell lymphomas (CTCLs), including mycosis fungoides (MF) and Sézary syndrome (SS), are rare hematological malignancies with limited curative treatment options. Despite early-stage responsiveness, these malignancies often relapse in advanced
Deniz Özistanbullu +19 more
doaj +2 more sources
“Next top” mouse models advancing CTCL research
Frontiers in Cell and Developmental BiologyThis review systematically describes the application of in vivo mouse models in studying cutaneous T-cell lymphoma (CTCL), a complex hematological neoplasm.
Yixin Luo +3 more
doaj +3 more sources
Microtextualidades, 2023 Existen elementos formales en el campo de la micro-ficción sobre los cuales la crítica especializada ha llegado a un acuerdo: la brevedad temporal y espacial; el doble movimiento de un discurso identitario junto con una mirada transcultural; la ...
María Alma Moran
doaj +1 more source
Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma
Frontiers in Oncology, 2021 Cutaneous T-cell lymphomas (CTCLs) comprise a group of heterogeneous diseases involving malignant T cells. The pathogenesis and etiology of CTCL are still unclear, although a large number of genetic and epidemiological studies on CTCL have been conducted.
Ping Zhang, Ping Zhang, Mingzhi Zhang
doaj +1 more source
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Dermatology and Therapy, 2023 Background The risk of developing cutaneous T cell lymphoma (CTCL) in patients using psoriasis biologics has not been well characterized. The goals of this review were to investigate the incidence of CTCL in patients with psoriasis receiving biologic ...
Mitchell S. Davis +7 more
doaj +1 more source
Frontiers in Immunology, 2023 Cutaneous T-cell lymphomas (CTCL) are characterized by focal infiltration of malignant T cell clones in solitary skin lesions. Many CTCL patients experience an indolent disease, but some progress to advanced disease with high fatality.
Andrea Scheffschick +11 more
doaj +1 more source
International Journal of Women's Dermatology, 2021 Cutaneous T-cell lymphoma (CTCL) encompasses a group of low-grade, non-Hodgkin lymphoma, including mycosis fungoides and Sézary syndrome. Diagnosis of CTCL can be challenging given the prolonged, gradual onset and shared characteristics with many benign ...
Sarah Semaan, BS +3 more
doaj +1 more source
Healthcare Provider Experience in Diagnosing and Treating Cutaneous T-Cell Lymphoma
Dermatology and Therapy, 2023 Introduction Cutaneous T-cell lymphoma (CTCL) is a rare, heterogeneous group of non-Hodgkin lymphomas characterized by various clinical, molecular, and histopathologic features of the skin.
Erin Boh +3 more
doaj +1 more source
Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma
Cells, 2022 Cutaneous T-Cell Lymphomas (CTCL) presents with substantial clinical variability and transcriptional heterogeneity. In the recent years, several studies paved the way to elucidate aetiology and pathogenesis of CTCL using sequencing methods.
Philipp Licht, Volker Mailänder
doaj +1 more source